1. Diagnostic-driven management of invasive fungal disease in hematology in the era of prophylaxis and resistance emergence: Dutch courage?. (10th July 2019) Authors: de Kort, E A; Maertens, J; Verweij, P E; Rijnders, B J A; Blijlevens, N M A Journal: Medical mycology Issue: Volume 57(2019)Supplement 3 Page Start: S267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Do the standards need modifications? A proposal for geotechnical stability safety factor of breakwater. Issue 1 (April 2021) Authors: Mollaert, J; Tavallali, A; Maertens, J Journal: IOP conference series Issue: Volume 727:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Liposomal amphotericin B—the present. (25th November 2022) Authors: Maertens, J; Pagano, L; Azoulay, E; Warris, A Journal: Journal of antimicrobial chemotherapy Issue: Volume 77(2022)Supplement 2 Page Start: ii11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis. (29th December 2020) Authors: Cruciani, M; White, P L; Mengoli, C; Löffler, J; Morton, C O; Klingspor, L; Buchheidt, D; Maertens, J; Heinz, W J; Rogers, T R; Weinbergerova, B; Warris, A; Lockhart, D E A; Jones, B; Cordonnier, C; Donnelly, J P; Barnes, R A Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 3(2021) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗